← Eichor
Condition: Sarcoma Uterus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sarcoma Uterus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · 12 location(s) · MacroGenics · NCT06242470Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · Kaiser Permanente · NCT07406087Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05542407Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · 55 location(s) · NRG Oncology · NCT05646316A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Phase 1 · 6 location(s) · SEED Therapeutics, Inc. · NCT07197554Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05187338Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04990076International PPB/DICER1 Registry
Phase N/A · 1 location(s) · Children's Hospitals and Clinics of Minnesota · NCT03382158Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center O
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06805019DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967Observational Study on Endometrial Stromal Tumors
Phase N/A · 13 location(s) · Italian Sarcoma Group · NCT02829437Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Phase N/A · 1 location(s) · Northwestern University · NCT00005095Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Phase N/A · 4 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05610501Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
Phase 3 · 5 location(s) · University of Utah · NCT03422198A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Phase 1 · 1 location(s) · GONGCHU Biotechnology Co., Ltd · NCT06508307IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Early Ageing During Therapy in AYA Cancer Patients
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT05062707Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
NA · 1 location(s) · Institut Claudius Regaud · NCT06967961A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Tanabe Pharma America, Inc. · NCT06943521Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Phase N/A · 3 location(s) · Mayo Clinic · NCT06349642Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
NA · 1 location(s) · Implenomics · NCT06004011A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · 6 location(s) · Kivu Bioscience Inc. · NCT07229313Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.